N

OR*

95% CI*

p-Value*

Age > median

185

0.97

0.57 - 1.65

0.9

Sex

185

Female

-

-

Male

0.78

0.50 - 1.23

0.3

Comorbidities

Hypertension

185

1.04

0.63 - 1.70

0.9

Diabetes

185

0.86

0.43 - 1.74

0.7

Exposure to a nephrotoxic product

185

0.85

0.46 - 1.58

0.6

Functional and general signs

Glasgow score < 15

185

3.68

2.26 - 5.97

<0.001

MAP < 60 mmHg

185

2.2

1.28 - 3.78

0.004

Source

185

Community

-

-

Hospital

1.09

0.68 - 1.75

0.7

Department of origin

60

Surgery

-

-

Medicine

6.11

1.44 - 26.0

0.014

Reasons for admission

Altered consciousness

185

2.31

1.48 - 3.58

<0.001

Respiratory distress

185

1.86

1.20 - 2.89

0.006

Anuria

0.65

0.2 - 2.06

0.5

Etiology

Hemorrhage

2.46

1.22 - 4.97

0.012

Decompensated hepatic cirrhosis

1.94

1.13 - 3.32

0.015

Severe sepsis

2.34

1.86 - 4.2

0.018

AKI stage (KDIGO 2012)

Stage 1

-

-

Stage 2

2.22

1.03 - 4.78

0.043

Stage 3

3.53

1.65 - 7.57

0.001

Number of multiple organ failures

1.87

1.58 - 2.21

<0.001

Treatment methods

Hemodialysis performed

33

0.29

0.04 - 2.18

0.2

Vascular filling

1.09

0.63 - 1.89

0.8

Vasopressive amines

2.2

1.41 - 3.44

<0.001